Intrinsic Value of S&P & Nasdaq Contact Us

Accolade, Inc. ACCD NASDAQ

NASDAQ Global Select • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
40/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.03
+0.1%

Stock Statistics — ACCD

Accolade, Inc. (ACCD) has a market capitalization of $575.59M and trades at $7.02. The 52-week range is 3.08-9.67.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -5.3, Earnings Per Share (EPS) of $-1.33, annual revenue of $414.29M.

The stock has a beta of 2.10, operates in the Healthcare sector.

Trading Data
Current Price$7.02
52-Week Range3.08-9.67
Volume4.54M
Avg Volume (30D)1.57M
Market Cap$575.59M
Beta (1Y)2.10
Company
IPO Date2020-07-01
Employees2,400
CEORajeev Singh
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS00437E1029
CUSIP00437E102
Income (Latest Year)
Revenue$414.29M
Gross Profit$192.06M
EBITDA$-69.29M
Operating Income$-114.45M
Net Income$-99.81M
EPS$-1.33
EPS Diluted$-1.33
Shares Outstanding$74.91M
Balance Sheet (Latest Year)
Total Assets$788.15M
Current Assets$284.91M
Cash & ST Investments$237.03M
Total Liabilities$342.69M
Total Debt$241.65M
Net Debt$55.93M
Total Equity$445.47M
Debt / Equity0.54
Valuation Ratios
P/E Ratio-5.3
P/S Ratio1.39
P/B Ratio1.29
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message